[go: up one dir, main page]

AU2015904350A0 - Composition and methods for the prevention and treatment of muscle atrophy - Google Patents

Composition and methods for the prevention and treatment of muscle atrophy

Info

Publication number
AU2015904350A0
AU2015904350A0 AU2015904350A AU2015904350A AU2015904350A0 AU 2015904350 A0 AU2015904350 A0 AU 2015904350A0 AU 2015904350 A AU2015904350 A AU 2015904350A AU 2015904350 A AU2015904350 A AU 2015904350A AU 2015904350 A0 AU2015904350 A0 AU 2015904350A0
Authority
AU
Australia
Prior art keywords
prevention
treatment
composition
methods
muscle atrophy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015904350A
Inventor
Peter M. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Peter M Dr
Original Assignee
Smith Peter M Dr
Filing date
Publication date
Application filed by Smith Peter M Dr filed Critical Smith Peter M Dr
Publication of AU2015904350A0 publication Critical patent/AU2015904350A0/en
Abandoned legal-status Critical Current

Links

AU2015904350A 2015-10-23 Composition and methods for the prevention and treatment of muscle atrophy Abandoned AU2015904350A0 (en)

Publications (1)

Publication Number Publication Date
AU2015904350A0 true AU2015904350A0 (en) 2015-11-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP3576776A4 (en) Compositions and methods for treating heart failure
EP3602606A4 (en) Surface treatment methods and compositions therefor
EP3408344A4 (en) Well treatment methods and compositions
AU2018297285A1 (en) Compositions and methods for treating or preventing endocrine FGF-linked diseases
EP3558279A4 (en) Compositions and methods for the treatment of chronic pain
EP3538189A4 (en) Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
EP3720421A4 (en) Compositions and methods for the treatment of metabolic conditions
IL262830A (en) Compositions and methods for treating spinal muscular atrophy
EP3429584A4 (en) Compositions and methods for the treatment of presbyopia
EP3310783A4 (en) Methods and compositions for the prevention and treatment of hearing loss
EP3634431A4 (en) Therapeutic compositions and methods for treating hepatitis b
EP3522873A4 (en) Compositions and methods for the treatment of xerostomia
EP3368048A4 (en) Methods and compositions for the treatment of amyloidosis
EP3253211A4 (en) Compositions and methods for treatment of edema
PT3283064T (en) Derivatives used in the treatment of muscle atrophy
EP3349719A4 (en) Compositions and methods for the treatment and prevention of radiation dermatitis
ZA201900984B (en) Methods and compositions for the treatment of warts
EP3110435A4 (en) Methods and compositions for the delayed treatment of stroke
EP3525787A4 (en) Methods of treatment and pharmaceutical compositions using bcn057 or bcn512
EP3294294A4 (en) Compositions and methods for the treatment or prevention of pulmonary hypertension
EP3534924A4 (en) Composition for the prevention and/or treatment of cardiovascular diseases
EP3554494A4 (en) Compositions and methods for the treatment of inflammation
EP3104940A4 (en) Compositions and methods for the prevention and/or treatment of schistosomiasis
AU2015904350A0 (en) Composition and methods for the prevention and treatment of muscle atrophy